Skip to content

Evaluation of Olmesartan on the Control of Morning Blood Pressure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003238
Enrollment
236
Registered
2010-02-28
Start date
2005-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Take medicine after breakfast Take medicine after supper

Sponsors

Kanagawa Association of Medical and Dental Practitioners
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient whose systolic blood pressure (BP) is over 140mmHg and/or diastolic BP is 90mmHg and not receives medication.

Exclusion criteria

Exclusion criteria: Exclusion criteria as follows: Patients who are pregnant or possibility of pregnancy, possess hypersensitivity to olmesartan, who are suffering from secondary hypertension, lateral or bilateral stenosis of renal arteries, cerebro-vascular diseases, hyper-potassemia, severe hepatic diseases, or elevated creatinine over 3.0mg/dl. Patient who are taking NSAID or steroids regularly, who are less than 15 years old, who are suffering from malignant neoplasm. Patients who are not selected by attendant physician.

Design outcomes

Primary

MeasureTime frame
Morning home blood pressure

Secondary

MeasureTime frame
renin, angiotensin, aldosterone,Urinary albumin, hs-CRP

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026